PT
Pliant Therapeutics Inc
🇩🇪XFRA.9PTGermanyHealthcare
€0.95EURdown -0.03 (-3.06%)OpenEnd of day6:24 AM
Price€0.95-0.03 (-3.06%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US7291391057
- CUSIP
- Not reported
Company
- Employees
- 49
- Headquarters
- South San Francisco, United States
- Website
- https://pliantrx.com
- CEO
- Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Market
- Shares outstanding
- 61.9M
- Market cap
- €58.82M
Highlights
- Market cap
- €58.82M
- EPS LTM
- -$1.49
- P/E LTM
- -0.78
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$92.29M+55.41%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$70.9M+58.51%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.